IBM’s Sale of Healthcare Data and Analytics Assets to Francisco Partners

On January 21, 2022, IBM and Francisco Partners, a global investment firm that specializes in partnering with technology businesses, announced that the companies have signed a definitive agreement under which Francisco Partners will acquire healthcare and data analytics assets from IBM that are currently part of the Watson Health business. The assets acquired by Francisco Partners include extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings. Cravath is representing IBM in connection with the transaction.

The Cravath team is led by partners George F. Schoen and Bethany A. Pfalzgraf and includes associates Richard E. Schwartz, Blair Baker and Paul A. Bryant on M&A matters; partner Matthew M. Kelly and associate Temiloluwa A. Dele‑Dare on financing matters; partner J. Leonard Teti II, senior attorney Andrew Carlon and associate Carlos Nicholas Obando on tax matters; partner Jonathan J. Katz and associates Christopher C. Gonnella, Brendon J. Rivard and David Crampton on executive compensation and benefits matters; and senior attorney Joyce Law on real estate matters.